This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Biofrontera Dividends and Buybacks
Dividend criteria checks 0/6
Key information
n/a
Dividend yield
31.5%
Buyback Yield
Total Shareholder Yield
31.5%
Future Dividend Yield
n/a
Dividend Growth
n/a
Next dividend pay date
n/a
Ex dividend date
n/a
Dividend per share
n/a
Payout ratio
n/a
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if B8FE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if B8FE's dividend payments have been increasing.
Dividend Yield vs Market
Biofrontera Dividend Yield vs Market
How does B8FE dividend yield compare to the market?
Segment
Dividend Yield
Company (B8FE)
n/a
Market Bottom 25% (DE)
1.7%
Market Top 25% (DE)
4.8%
Industry Average (Pharmaceuticals)
1.3%
Analyst forecast (B8FE) (up to 3 years)
n/a
Notable Dividend: Unable to evaluate B8FE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate B8FE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as B8FE has not reported any payouts.